News Steve Paul reignites xanomeline research as Karuna CEO Karuna aims to overcome safety concerns with combination therapy
News UK's Artios raises $84m to further DDR drug research Management team led development of AZ's PARP drug Lynparza
Partner Content Partner Content Prescient Healthcare Group Strengthens Its US Leadership Tea... Dr. Paul Harney Joins the Prescient Team
Events Partner Content 7th Annual Pharma Anti-Counterfeiting & Serialisation 20... 7th Annual Pharma Anti-Counterfeiting & Serialisation 2018 “Competences to Combat Counterfeits”
Events Partner Content 16th Pharmacovigilance 2018 16th Pharmacovigilance 2018 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"
News UK biotech riding on crest of VC funding wave - report Venture capital funding for the UK biotech sector is robust following a solid start to the year, according to new data.
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
